Menu

Blog

Archive for the ‘health’ category: Page 77

Dec 19, 2022

Scientists use machine learning to get an unprecedented view of small molecules

Posted by in categories: biotech/medical, chemistry, health, robotics/AI

A new machine learning model will help scientists identify small molecules, with applications in medicine, drug discovery and environmental chemistry. Developed by researchers at Aalto University and the University of Luxembourg, the model was trained with data from dozens of laboratories to become one of the most accurate tools for identifying small molecules.

Thousands of different small molecules, known as , transport energy and transmit cellular information throughout the human body. Because they are so small, metabolites are difficult to distinguish from each other in a blood sample analysis—but identifying these molecules is important to understand how exercise, nutrition, and metabolic disorders affect well-being.

Metabolites are normally identified by analyzing their mass and retention time with a separation technique called liquid chromatography followed by mass spectrometry. This technique first separates metabolites by running the sample through a column, which results in different flow rates—or retention times—through the measurement device.

Dec 19, 2022

How a common cold develops

Posted by in categories: biotech/medical, health

Winter and rainy season is worst for those who have low immunity. Antibiotics have many side effects. But there high fever due to viral infection is also risky.


A cold is an infection caused by a virus. It’s a common and usually mild illness that affects the nose and throat. Find out more here: http://bit.ly/KV8y1c.

Continue reading “How a common cold develops” »

Dec 19, 2022

FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer

Posted by in categories: biotech/medical, health

MONDAY, Dec. 19, 2022 (HealthDay News) — Patients with a high-risk bladder cancer now have a new option to treat it.

The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what’s called high-risk non-muscle-invasive bladder cancer (NMIBC) that hasn’t responded to the standard treatment, Bacillus Calmette-Guérin (BCG), but hasn’t spread. BCG is a vaccine typically used for tuberculosis.

“This approval provides health care professionals with an innovative treatment option for patients with high-risk NMIBC that is unresponsive to BCG therapy,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an agency news release. “Today’s action addresses an area of critical need. The FDA remains committed to facilitating the development and approval of safe and effective cancer treatments.”

Dec 17, 2022

Scientists create world’s first ‘Vagina-on-a-Chip’ to combat bacterial diseases

Posted by in categories: biotech/medical, health

Researchers at the Wyss Institute at Harvard University have engineered the first-ever “Vagina on a Chip” in the world that replicates the human vaginal tissue microenvironment in vitro, Scientific American reported on Wednesday.

It is composed of the human vaginal epithelium and underlying connective tissue cells and it replicates many of the physiological features of the vagina, according to Harvard.

Best of all, it can be inoculated with different strains of bacteria allowing researchers to study their effects on the organ’s health.

Dec 16, 2022

Gates and Bezos back Neuralink-competitor Synchron in a new funding

Posted by in categories: biotech/medical, business, computing, health, neuroscience

Many investors are jumping to inject money into the startup.

Bill Gates and Jeff Bezos-backed foundations (Gates Frontier and Bezos Expeditions) have joined other companies in investing $75 million in Synchron, the endovascular brain-computer interface (BCI) company, according to a press release by the organization published on Thursday. This is a Series C financing round led by ARCH Venture Partners that brings the total amount raised since inception to $145 million.

Many investors on board.

Continue reading “Gates and Bezos back Neuralink-competitor Synchron in a new funding” »

Dec 15, 2022

The Rise of OpenAI With Sam Altman (OpenAI CEO) | Moonshots and Mindsets

Posted by in categories: health, robotics/AI

In this episode, filmed in early 2021, Sam and Peter discuss the creation of OpenAI and GPT-3, what the future of OpenAI will bring to humanity, and the power of AI/Human collaboration.

Sam Altman is the Co-Founder and CEO of OpenAI and former president of Y Combinator. OpenAI is an artificial intelligence research laboratory that creates programs, such as GPT-3, ChatGPT, and DALL-E 2, for the benefit of humanity.

Continue reading “The Rise of OpenAI With Sam Altman (OpenAI CEO) | Moonshots and Mindsets” »

Dec 15, 2022

Neurobiology Understanding the Big 6 Neurotransmitters

Posted by in categories: biotech/medical, education, health, neuroscience

What are #dopamine, #serotonin, norepinephrine, glutamate, #GABA, acetylcholine? What does dopamine do?
📢SUBSCRIBE and click the BELL to get notified when new videos are uploaded.
💲 AllCEUs.com Unlimited continuing education CEUs $59
💻 Online course based on this video can be found at AllCEUs.com/NEURO-CEU https://www.allceus.com/member/cart/index/product/id/96/c/
⭐ Specialty Certificate Programs for Case Management and Counselor Certification beginning at $89 https://AllCEUs.com/certificate-tracks.

Join this channel to get access to perks:
https://www.youtube.com/channel/UCAE3JJi8tX7gfhZEXCUGd_A/join.

Continue reading “Neurobiology Understanding the Big 6 Neurotransmitters” »

Dec 15, 2022

Dr Loren Matheson, PhD — Centre for Security Science, DRDC — Leading Canada’s Safety & Security R&D

Posted by in categories: biotech/medical, chemistry, food, government, health, policy, science, security

Leading Canada’s Bio-Safety & Security R&D — Dr. Loren Matheson PhD, Defence Research and Development Canada, Department of National Defence.


Dr. Loren Matheson, Ph.D. is a Portfolio Manager at the Center For Security Science, at Defence Research and Development Canada (DRDC — https://www.canada.ca/en/defence-research-development.html), which is a special operating agency of the Department of National Defence, whose purpose is to provide the Canadian Armed Forces, other government departments, and public safety and national security communities with knowledge and technology.

Continue reading “Dr Loren Matheson, PhD — Centre for Security Science, DRDC — Leading Canada’s Safety & Security R&D” »

Dec 14, 2022

China will regulate AI-generated content with a new set of regulations

Posted by in categories: health, internet, robotics/AI

The rules will go into effect starting in 2023.

China has issued rules and guidelines that regulate the use of artificial intelligence within the country. The regulations are cautious when it comes to AI. This includes the trending AI chatbots, such as ChatGPT, AI-generated art, the many methods of utilizing AI in the health care sector and all forms of artificial intelligence, in general.

The Cyberspace Administration of China (CAC), has issued a set of rules to follow when incorporating AI. The CAC is the internet regulator and censor in China. The agency released guidelines on “deep synthesis”. The regulatory measures will take effect starting on Jan. 10, 2023.

Continue reading “China will regulate AI-generated content with a new set of regulations” »

Dec 14, 2022

Magic Truffles And Me: Can Psilocybin Make The Brain Young Again?

Posted by in categories: health, neuroscience

One writer embarks upon the trip of a lifetime at Field Trip Health, a very particular kind of wellness clinic in Amsterdam, and recounts her experience of “macrodosing” psilocybin.

Page 77 of 381First7475767778798081Last